LobbyingAmerican Society of Radiologic Technologists lobbying by quarter
American Society of Radiologic Technologists's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
American Society of Radiologic Technologists
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 14 reports
- Medicare and Medicaid$0 · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Society of Radiologic Technologists | $0 | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/15for Q2 | In-house | Under $5,000 |
| 04/08for Q1 | In-house | Under $5,000 |
| 01/13for Q4 2025 | In-house | Under $5,000 |
| 25/10/15for Q3 2025 | In-house | Under $5,000 |
| 25/07/08for Q2 2025 | In-house | Under $5,000 |
| 25/04/02for Q1 2025 | In-house | Under $5,000 |
| 25/01/14for Q4 2024 | In-house | Under $5,000 |
| 24/10/09for Q3 2024 | In-house | Under $5,000 |
| 24/07/09for Q2 2024 | In-house | Under $5,000 |
| 24/04/04for Q1 2024 | In-house | Under $5,000 |
| 24/01/17for Q4 2023 | In-house | Under $5,000 |
| 23/10/16for Q3 2023 | In-house | Under $5,000 |
| 23/07/17for Q2 2023 | In-house | Under $5,000 |
| 23/04/04for Q1 2023 | In-house | Under $5,000 |
| 23/02/24for Q1 2023 | In-house | Under $5,000 |